Category: Pakistan

JMGO Set to Ace Laser Projection with MALC™ 2.0 Triple Laser Optics at IFA 2024

Setting new standards for the projector industry with epic brightness, contrast, and color reproduction—achieved all at once JMGO Set to Ace Laser Projection with MALC™ 2.0 Triple Laser Optics at IFA 2024 BERLIN, Sept. 04, 2024 (GLOBE NEWSWIRE) —  JMGO, a pioneer in optical technology, will showcase its in-house developed MALC™ (Microstructure Adaptive Laser Control) […]

Read More

Integrated Power Services Acquires Assets of ABB Industrial Services Business

Acquisition Adds Electric Motor, Generator, Mechanical, Switchgear & Circuit Breaker Service Centers to IPS’s Growing North American Network IPS President and CEO John Zuleger GREENVILLE, S.C., Sept. 03, 2024 (GLOBE NEWSWIRE) — Integrated Power Services (IPS), a North American leader in the servicing, engineering, and remanufacturing of electrical, mechanical, and power management systems, has finalized […]

Read More

Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to “Thank God I Got It” by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio

NAPLES, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG), a leading entity in the music industry, is excited to announce the acquisition of the royalty rights to “Thank God I Got It” by the renowned artist Desiigner. This acquisition underscores Music Licensing, Inc.’s commitment to diversifying its portfolio with high-quality, revenue-generating […]

Read More

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to […]

Read More